Open access announcements, the gene patent debate, and an ORCID rollout date, OH MY!

It was a big week for open access announcements. The UK announced a plan for open access of all publicly funded research in two years on Monday. (In a post on her blog, Maria Pretzler asks who will pay.) Following hot on their heels, the European Commission released recommendations for member states on access to and preservation of publicly funded scientific research Tuesday. The New Scientist also covered the topic.

According to the NY Times, gene therapy is nearing regulatory approval in Europe.

The Daily Scan reports on James Watson’s amicus brief in the ACLU-Myriad gene patenting case. Nature News has a piece on how the case could affect personalized medicine.

The ORCID (Open Researcher and Contributor ID) registry, the goal of which is to “solve the long-standing name ambiguity problem in scholarly communication” has announced it will go live this October!